News|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)Pharmaceutical Technology Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
FDA Deploys Agentic AI Capabilities for Agency Staff
3
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
